--- title: "M&A, Poison Pills, and Capital Restructuring Drive US Mid-Cap Realignments" type: "News" locale: "en" url: "https://longbridge.com/en/news/293818438.md" description: "McCormick advances its USD 44.8 billion Unilever integration while Greenland Mines deploys defensive poison pills. From Enbridge’s infrastructure expansion to Neuronetics' executive reshuffles, mid-cap equities are aggressively navigating capital reallocations and strategic shifts." datetime: "2026-07-25T09:13:31.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293818438.md) - [en](https://longbridge.com/en/news/293818438.md) - [zh-HK](https://longbridge.com/zh-HK/news/293818438.md) generator: "portal-rs" --- # M&A, Poison Pills, and Capital Restructuring Drive US Mid-Cap Realignments US equities across specialized sectors are accelerating capital deployments and corporate restructuring in mid-2026, targeting infrastructure expansion and aggressive M&A integration, according to recent corporate disclosures. In the consumer staples space, McCormick & Company Inc (MKC.US) is advancing its **USD 44.8B** acquisition of Unilever's food business—announced in March 2026—while confirming plans on July 23 for a secondary listing in London. The company reported Q2 2026 net sales of **USD 1.936B**, up **16.7%** year-over-year. Energy infrastructure is similarly seeing massive capital commitments. Enbridge Inc (ENB.US) expanded its secured project backlog to **USD 40B** in Q1 and recently secured Canadian approval for its **USD 4B** Sunrise Expansion program. Meanwhile, midstream operator Delek Logistics Partners LP (DKL.US) hit a 52-week high, surging over **40%** over the past year, after raising its quarterly distribution to **USD 1.135** per unit and pricing an **USD 800M** note offering due 2034. Corporate defensive maneuvers and strategic financing are accelerating elsewhere. Greenland Mines Ltd (GRML.US) adopted a one-year shareholder rights plan on July 23 to block hostile takeovers after reporting a **31%** resource increase at its Skaergaard project. In the biotech sector, Agenus Inc (AGEN.US) secured up to **USD 340M** in private financing to push its BOT+BAL combination therapy trials after presenting **33%** three-year overall survival data at ESMO GI 2026. Medical tech firm Neuronetics Inc (STIM.US) is restructuring its C-suite, appointing Nir Naor as CFO following Q1 revenue of **USD 34.5M** that beat consensus despite missing EPS targets. Operational realignments are driving tech and logistics names. Calix Inc (CALX.US) is securing multiple rural cooperative deals for its AI-native platform in July, even as the company faces a securities fraud class action over undisclosed margin impacts from memory pre-commitments. Maritime shipper C3is Inc (CISS.US) executed a 1-for-7 reverse stock split to regain compliance while expanding its fleet, reporting a **358%** surge in Q1 adjusted net income to **USD 5.5M**. Broadly, utility and infrastructure plays like American Water Works Company Inc (AWK.US) and Hyperscale Data Inc (GPUS.US) continue to navigate normalized capital expenditure cycles as sector-wide infrastructure investments peak. *This article does not constitute investment advice.* ### Related Stocks - [DKL.US](https://longbridge.com/en/quote/DKL.US.md) - [CISS.US](https://longbridge.com/en/quote/CISS.US.md) - [ENB.US](https://longbridge.com/en/quote/ENB.US.md) - [STIM.US](https://longbridge.com/en/quote/STIM.US.md) - [GRML.US](https://longbridge.com/en/quote/GRML.US.md) - [CALX.US](https://longbridge.com/en/quote/CALX.US.md) - [AWK.US](https://longbridge.com/en/quote/AWK.US.md) - [AGEN.US](https://longbridge.com/en/quote/AGEN.US.md) - [GPUS.US](https://longbridge.com/en/quote/GPUS.US.md) - [MKC.US](https://longbridge.com/en/quote/MKC.US.md) ## Related News & Research - [Enbridge (TSE:ENB) Stock Rating Upgraded by US Capital Advisors](https://longbridge.com/en/news/296615818.md) - [Ontario Teachers Pension Plan Board Acquires Shares of 707,069 American Water Works Company, Inc. $AWK](https://longbridge.com/en/news/296339472.md) - [Agenus posts investor deck spotlighting botensilimab-balstilimab neoadjuvant program in MSS colon cancer](https://longbridge.com/en/news/296536017.md) - [Should a Hawaii Spill and New Upgrades Shift How Investors View American Water Works’ (AWK) Risk‑Reward?](https://longbridge.com/en/news/296250827.md) - [US Capital Advisors Predicts Increased Earnings for Enbridge](https://longbridge.com/en/news/296613073.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**